Clinical Characteristics and Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease with Chronic Pulmonary Aspergillosis in Patients
Preprint
- 7 January 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background: The incidence of patients with nontuberculous mycobacterial pulmonary disease (NTM-PD) complicated by chronic pulmonary aspergillosis (CPA) has been increasing. CPA is known to be associated with complex treatment regimens and a poor prognosis. However, data from mainland China remain scarce. Objective: This single-center retrospective study aimed to evaluate the clinical characteristics, risk factors, and prognoses of patients with NTM-PD who were coinfected with CPA. Methods: We conducted a retrospective review of the medical records of 248 patients diagnosed with NTM-PD. Risk factors for CPA were analyzed via multiple logistic regression, followed by survival analysis. Results: Among the 248 patients with NTM-PD, 66 (26.6%) were diagnosed with CPA. Independent risk factors for NTM-PD and CPA coinfection included male sex(OR 2.13, 95% CI:1.03-4.47), dyspnea(OR 27.9, 95% CI:4.24-570), cavity(OR 5.95, 95% CI:2.76-13.9), use of oral corticosteroids(OR 4.28, 95% CI:1.13-16.6), and interstitial lung disease(OR 15.5, 95% CI:1.89-361). The Kaplan-Meier survival curves indicated a significant divergence between the NTM-PD group and the NTM-PD with CPA group (log-rank test, p = 0.00039; HR 2.01, 95% CI:0.66-6.12). Conclusion: In patients with NTM-PD, the presence of concurrent CPA is associated with a marked increase in mortality. Clinicians should maintain a high index of suspicion for CPA to ensure prompt diagnosis and treatment, particularly in high-risk individuals.Keywords
All Related Versions
- Version 1, 2026-01-07, Preprints
- Published version: Journal of Clinical Medicine, 15 (4), 1561.
This publication has 23 references indexed in Scilit:
- Epidemiology and laboratory detection of non-tuberculous mycobacteriaHeliyon, 2024
- Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standardClinical Microbiology and Infection, 2023
- Nontuberculous mycobacterial pulmonary disease and associated risk factors in China: A prospective surveillance studyJournal of Infection, 2021
- Impact of Aspergillus precipitating antibody test results on clinical outcomes of patients with Mycobacterium avium complex lung diseaseRespiratory Medicine, 2020
- Antibiotic therapy success rate in pulmonary Mycobacterium avium complex: a systematic review and meta-analysisExpert Review of Anti-infective Therapy, 2020
- Risk stratification for the development of chronic pulmonary aspergillosis in patients with Mycobacterium avium complex lung diseaseJournal of Infection and Chemotherapy, 2018
- Prognosis of chronic pulmonary aspergillosis in patients with pulmonary non-tuberculous mycobacterial diseaseRespiratory Investigation, 2018
- The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteriaMedical Mycology, 2015
- Inhaled corticosteroids and Aspergillus fumigatus isolation in cystic fibrosisMedical Mycology, 2014
- Risk of Infectious Complications in Patients Taking GlucocorticosteroidsClinical Infectious Diseases, 1989